← Open Payments lookup

ARUNA GULLAPALLI: Open Payments

NPI 1154303261 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$946 in 55 payments from 13 companies in 2025. Trend: 2023 $1,257 · 2024 $741 · 2025 $946

Food & beverage: $946
CompanyPaymentsAmount
ABBVIE INC.26$294
Neurocrine BioSciences, Inc.5$144
Alkermes, Inc.4$84
Corium, LLC3$82
Takeda Pharmaceuticals U.S.A., Inc.4$77
Otsuka America Pharmaceutical, Inc.3$62
Vanda Pharmaceuticals Inc.3$61
E.R. Squibb & Sons, L.L.C.2$39
Janssen Pharmaceuticals, Inc1$30
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$22

Products named: VRAYLAR, INGREZZA, ARISTADA, Azstarys, TRINTELLIX, FANAPT, REXULTI, COBENFY.

Industry payments across LA — which companies pay providers there.